Skip to main content
SpringerLink
Log in

The Role of Primary Care in Bariatric Surgery

  • Reference work entry
  • First Online:
Obesity, Bariatric and Metabolic Surgery

  • 65 Accesses

Abstract

The primary care physician plays an important role in the early identification and engagement of overweight or obese individuals and in the management of their weight in association with global risk. Should first-line measures fail to induce sufficient weight reduction or adequate risk control or amelioration of comorbidities, the primary care provider is in a position to assess eligibility, suitability, and willingness for surgery, to discuss the options with the patient, and to make an informed, appropriate referral. Postoperatively, the general practitioner (GP) should anticipate an urgent communication from the tertiary care center to alert them that a patient with rapidly changing physiology is residing under their care in the community. Recent studies of COVID-19 (Corona virus disease-19) patients suggest that obese individuals who have had bariatric surgery have a greatly reduced risk of hospitalization, critical care, and death from COVID-19 infection, compared with obese individuals who have not had surgery. This is likely due to the improvements in metabolic abnormalities seen after surgery. In the long-term, the role of the GP is lifelong monitoring and managing of the individual who has undergone bariatric surgery. The GP is guided by the awareness of nutritional and metabolic sequelae of bariatric surgery as along with the enhanced risk status under which many of these patients remain.

David William Haslam: deceased.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 599.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ziegler O, Sirveaux MA, Brunaud L, Reibel N, Quilliot D. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab. 2009;35(6 Pt 2):544–57. https://doi.org/10.1016/S1262-3636(09)73464-0.

    Article  CAS  Google Scholar 

  2. National Health Service. HES on obesity [Internet]. YYYY [cited YYYY MON DD]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/hes-on-obesity

  3. Tigbe WW, Briggs AH, Lean ME. A patient-centred approach to estimate total annual healthcare cost by body mass index in the UK counterweight programme. Int J Obes. 2013;37(8):1135–9. https://doi.org/10.1038/ijo.2012.186.

    Article  CAS  Google Scholar 

  4. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, et al. Comparison of the Atkins, zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the a TO Z weight loss study: a randomized trial. JAMA. 2007;297(9):969–77. https://doi.org/10.1001/jama.297.9.969.

    Article  CAS  Google Scholar 

  5. Papadaki A, Linardakis M, Larsen TM, van Baak MA, Lindroos AK, Pfeiffer AF, et al. The effect of protein and glycemic index on children’s body composition: the DiOGenes randomized study. Pediatrics. 2010;126(5):e1143–52. https://doi.org/10.1542/peds.2009-3633.

    Article  Google Scholar 

  6. Saeidifard F, et al. The effect of replacing sitting with standing on cardiovascular risk factors: a systematic review and meta-analysis. Mayo Clin Proc Innov Qual Outcomes. 2020;4(6):611–26. https://doi.org/10.1016/j.mayocpiqo.2020.07.017.

    Article  Google Scholar 

  7. Castelnuovo G, et al. Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives. Psychol Res Behav Manag. 2017;10:165–73. https://doi.org/10.2147/PRBM.S113278.

    Article  Google Scholar 

  8. Jolly K, Daley A, Adab P, Lewis A, Denley J, Beach J, et al. A randomised controlled trial to compare a range of commercial or primary care led weight reduction programmes with a minimal intervention control for weight loss in obesity: the lighten up trial. BMC Public Health. 2010;10:439. https://doi.org/10.1186/1471-2458-10-439.

    Article  Google Scholar 

  9. The Counterweight Project Team. Evaluation of the counterweight programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract. 2008;58(553):548–54. https://doi.org/10.3399/bjgp08X319710.

    Article  Google Scholar 

  10. Nanchahal K, Power T, Holdsworth E, Hession M, Sorhaindo A, Griffiths U, et al. A pragmatic randomised controlled trial in primary care of the Camden Weight Loss (CAMWEL) programme. BMJ Open. 2012;2(3):e000793. https://doi.org/10.1136/bmjopen-2011-000793.

    Article  Google Scholar 

  11. Look AHEAD. Research group, wing RR, Bolin P, Brancati FL, bray GA, Clark JM, et al. cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. https://doi.org/10.1056/NEJMoa1212914.

    Article  CAS  Google Scholar 

  12. Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group Lancet. 1998;352(9123):167–72. https://doi.org/10.1016/s0140-6736(97)11509-4.

    Article  Google Scholar 

  13. Khera R, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34. https://doi.org/10.1001/jama.2016.7602.

    Article  CAS  Google Scholar 

  14. Koutroumanidou E, Pagonopoulou O. Combination of very low energy diets & pharmacotherapy in the treatment of obesity: meta-analysis of published data. Diabetes Metab Res Rev. 2014;30(3):165–74. https://doi.org/10.1002/dmrr.2475.

    Article  Google Scholar 

  15. Philip W, James T, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363:905–17. https://doi.org/10.1056/NEJMoa1003114.

    Article  Google Scholar 

  16. Caterson ID, et al. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes, Obesity and Metabolism. 14(6):523–30. https://doi.org/10.1111/j.1463-1326.2011.01554.x.

  17. European drugs agency withdraws antiobesity drug. BMJ. 2008;337:a2301.

    Article  Google Scholar 

  18. Katey Davidson K, Van De Walle G. Does phentermine work for weight loss? a diet pill reviewed. Nutrition. 2021;

    Google Scholar 

  19. David J, et al. Phentermine/topiramate extended-release capsules (Qsymia) for weight loss. NIH Pubmed Central. 2013;38((8):446):449–52.

    Google Scholar 

  20. Brown J, Everett B. Cardioprotective diabetes drugs: what cardiologists need to know. Cardiovasc Endocrinol Metab. 2019;8(4):96–105. https://doi.org/10.1097/XCE.0000000000000181.

    Article  CAS  Google Scholar 

  21. Wilding J, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002. https://doi.org/10.1056/NEJMoa2032183.

    Article  CAS  Google Scholar 

  22. Brown E, et al. Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities. Obesity Rev. 20(6):816–28. https://doi.org/10.1111/obr.12841

  23. Aldekhail NM, et al. The association between diabetes medication and weight change in a nonsurgical weight management intervention: an intervention cohort study. Diabet Med. 2020;37(2):248–55. https://doi.org/10.1111/dme.14093. Epub 2019 Sep 3

    Article  CAS  Google Scholar 

  24. Wee CC, Huskey KW, Bolcic-Jankovic D, Colten ME, Davis RB, Hamel M. Sex, race, and consideration of bariatric surgery among primary care patients with moderate to severe obesity. J Gen Intern Med. 2014;29(1):68–75. https://doi.org/10.1007/s11606-013-2603-1.

    Article  Google Scholar 

  25. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes. 2009;33(3):289–95. https://doi.org/10.1038/ijo.2009.2.

    Article  CAS  Google Scholar 

  26. Mitchell JE, Crosby R, de Zwaan M, Engel S, Roerig J, Steffen K, et al. Possible risk factors for increased suicide following bariatric surgery. Obesity (Silver Spring). 2013;21(4):665–72. https://doi.org/10.1002/oby.20066.

    Article  Google Scholar 

  27. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. https://doi.org/10.1001/jama.2011.1914.

    Article  Google Scholar 

  28. Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25. https://doi.org/10.1001/jama.2013.280928.

    Article  CAS  Google Scholar 

  29. Ravesloot MJ, Hilgevoord AA, van Wagensveld BA, de Vries N. Assessment of the effect of bariatric surgery on obstructive sleep apnea at two postoperative intervals. Obes Surg. 2014;24(1):22–31. https://doi.org/10.1007/s11695-013-1023-y.

    Article  CAS  Google Scholar 

  30. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. https://doi.org/10.1056/NEJMoa1200111.

    Article  CAS  Google Scholar 

  31. Felipo V, Urios A, García-Torres ML, El Mlili N, del Olmo JA, Civera M, et al. Alterations in adipocytokines and cGMP homeostasis in morbid obesity patients reverse after bariatric surgery. Obesity (Silver Spring). 2013;21(2):229–37. https://doi.org/10.1002/oby.20008.

    Article  CAS  Google Scholar 

  32. Pallati PK, Shaligram A, Shostrom VK, Oleynikov D, McBride CL, Goede MR. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the bariatric outcomes longitudinal database. Surg Obes Relat Dis. 2014;10(3):502–7. https://doi.org/10.1016/j.soard.2013.07.018.

    Article  Google Scholar 

  33. Knoepp LR, Semins MJ, Wright EJ, Steele K, Shore AD, Clark JM, et al. Does bariatric surgery affect urinary incontinence? Urology. 2013;82(3):547–51. https://doi.org/10.1016/j.urology.2013.04.042.

    Article  Google Scholar 

  34. Frank P, Crookes PF. Short- and long-term surgical follow-up of the postbariatric surgery patient. Gastroenterol Clin N Am. 2010;39(1):135–46. https://doi.org/10.1016/j.gtc.2009.12.011.

    Article  Google Scholar 

  35. Papamargaritis D, Koukoulis G, Sioka E, Zachari E, Bargiota A, Zacharoulis D, et al. Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy. Obes Surg. 2012;22(10):1600–6. https://doi.org/10.1007/s11695-012-0711-3.

    Article  Google Scholar 

  36. Malone M, Alger-Mayer SA. Medication use patterns after gastric bypass surgery for weight management. Ann Pharmacother. 2005;39(4):637–42. https://doi.org/10.1345/aph.1E393.

    Article  Google Scholar 

  37. Yska JP, van der Linde S, Tapper VV, Apers JA, Emous M, Totté ER, et al. Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes. Obes Surg. 2013;23(6):819–25. https://doi.org/10.1007/s11695-013-0882-6.

    Article  Google Scholar 

  38. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8(9):544–56. https://doi.org/10.1038/nrendo.2012.48.

    Article  CAS  Google Scholar 

  39. Lulsegged A, Saeed E, Langford E, Duffield C, El-Hasani S, Pareek N. Starvation ketoacidosis in a patient with gastric banding. Clin Med (Lond). 2011;11(5):473–5. https://doi.org/10.7861/clinmedicine.11-5-473.

    Article  CAS  Google Scholar 

  40. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, et al. American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & bariatric surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14(Suppl 1):1–83. https://doi.org/10.4158/EP.14.S1.1.

    Article  Google Scholar 

  41. Hallersund P, Sjöström L, Olbers T, Lönroth H, Jacobson P, Wallenius P, et al. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis—long term results from the Swedish obese subjects (SOS) study. PLoS One. 2012;7(11):e49696. https://doi.org/10.1371/journal.pone.0049696.

    Article  CAS  Google Scholar 

  42. Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93. https://doi.org/10.1056/NEJMoa035622.

    Article  Google Scholar 

  43. Bajardi G, Ricevuto G, Mastrandrea G, Latteri M, Pischedda G, Rubino G, et al. Prophylactic cholecystectomy in bariatric surgery. [article in Italian]. Minerva Chir. 1993;48(6):277–9.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Luton University Hospital and Visiting, Professor Chester University, Hon. Professor RGU Aberdeen, NHS GP Surgery, Watton, Stone, UK

    David William Haslam

  2. College of Contemporary Health, London, UK

    Nigel Hinchliffe

  3. Rotherham Institute for Obesity, Rotherham, South Yorkshire, UK

    Matthew S. Capehorn

Authors
  1. David William Haslam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nigel Hinchliffe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew S. Capehorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Homerton University Hospital, London, UK

    Sanjay Agrawal

Section Editor information

  1. Bariatric & Metabolic Surgery, UHCW NHS Trust, Coventry, United Kingdom

    Vinod Menon

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Haslam, D.W., Hinchliffe, N., Capehorn, M.S. (2023). The Role of Primary Care in Bariatric Surgery. In: Agrawal, S. (eds) Obesity, Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-60596-4_74

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-60596-4_74

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-60595-7

  • Online ISBN: 978-3-030-60596-4

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation